Evidence map›Paper›PMID 41194113›Full record

ArticleMolecular cancer2025

Spatial and functional dissection of cancer-associated fibroblasts-mediated immune modulation in H. pylori-associated gastric cancer.

Bonan Chen, Hongzhen Tang, Xiaohong Zheng, Fuda Xie, Peiyao Yu, Yang Lyu, Tiejun Feng, Jialin Wu, Jingya Liu, Yi Xu and 18 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Bonan ChenDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.ORCID http://orcid.org/0000-0002-2430-7934
Hongzhen TangSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Xiaohong ZhengThe Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
Fuda XieDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Peiyao YuDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Yang LyuDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Tiejun FengDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Jialin WuDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Jingya LiuGuangzhou University of Chinese Medicine, Guangzhou, China.
Yi XuDepartment of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Alvin H K CheungDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Canbin FangDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China.
Zhangding WangDepartment of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Shouyu WangDepartment of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Justin Chak Ting CheungDepartment of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
Yujuan DongDepartment of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ruoxi TianState Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Yigan ZhangInstitute of Biomedical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Cheng LuDepartment of Radiology, Guangdong Provincial People's Hospital, Medical Research Institute, Southern Medical University, Guangzhou, China.
Chi Chun WongState Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
Jun YuState Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
William K K WuDepartment of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
Elke BurgermeisterDepartment of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Man TongSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Fengbin ZhangDepartment of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. zhangfengbin1981@163.com.
Wei KangDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China. weikang@cuhk.edu.hk.ORCID http://orcid.org/0000-0002-4651-677X
Kam Tong LeungDepartment of Pediatrics, The Chinese University of Hong Kong, Hong Kong SAR, China. ktleung@cuhk.edu.hk.
Ka Fai ToDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong SAR, China. kfto@cuhk.edu.hk.ORCID http://orcid.org/0000-0003-4919-3707

Funding

CUHK Direct Research Grant 2024.066Hebei Provincial Major Science and Technology Support Plan International Scientific and Technological Cooperation/Hong Kong, Macau, and Taiwan Science and Technology Cooperation Project 25297706DNational Natural Science Foundation of China 82272990National Natural Science Foundation of China 82403017RGC Postdoctoral Fellowship Scheme UGC/GEN/562/3the NSFC-RGC Joint Research Scheme N_CUHK448/23
6 · The paper itself

Abstract

backgroundCancer-associated fibroblasts (CAFs) are key regulators of the tumor microenvironment, yet their spatial organization and immunomodulatory functions in H. pylori-associated gastric cancer (GC) remain incompletely understood.

methodsWe profiled formalin-fixed paraffin-embedded (FFPE) tumors from 71 GC patients using spatial transcriptomics and integrated single-cell RNA-seq from three independent cohorts (China, USA, and Singapore). CAF-immune cell colocalization was quantified by neighborhood enrichment and aggregation index score. Ligand-receptor inference and trajectory analysis resolved CAF signaling and state transitions. To delineate post-transcriptional control, ARE-motif scanning and expression correlations were combined with laser-assisted crosslinking and immunoprecipitation sequencing (LACE-seq) to nominate ZFP36 targets. Immune contexture and prognostic associations were evaluated using CIBERSORT-ABS and Kaplan-Meier analyses in The Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) cohorts.

resultsWe first defined the spatial distributions of the four CAF subtypes reported in prior studies and found that their immune associations varied across histologic and infection-defined GC subtypes. In H. pylori-positive tumors, THBS1⁺ CAFs were spatially enriched near regulatory T cells (Tregs) and were associated with local immunosuppression through WNT5-FZD interactions. In parallel, ZFP36 bound AU-rich elements within the FN1 3' untranslated region (3'UTR), destabilizing FN1 mRNA and thereby diminishing FN1⁺ CAF-mediated cytotoxic T lymphocyte (CTL) activation. Together, these axes promoted Treg accumulation and suppression of CTL activation.

conclusionsThese findings reveal infection-associated stromal programs that shape the immune landscape in GC and highlight CAF-directed pathways as potential therapeutic targets in H. pylori-associated GC.

Indexed as

Cancer-Associated FibroblastsHelicobacter InfectionsHelicobacter pyloriImmunomodulationStomach NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMalePrognosisTranscriptomeTumor MicroenvironmentCancer-associated fibroblastsGastric cancerH. pyloriLauren classificationSpatial transcriptomics

Identifiers

PMID41194113
PMCPMC12590883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.